The CML Clinical Trials data-base now lists 54 studies worldwide

15 Jan 2020 - 12:01

Our clinical trials registry currently lists 54 studies:

  • 32 CML studies actively recruiting patients, including
  • 2 paediatric trials
  • 7 treatment-free remission trials
  • 20 studies that are no longer recruiting

 

Check here CML Trials Registry 

 

We are pleased to share new trials from many countries worldwide, including:

  • INCB84344-102 = a paediatric trial to evaluate the safety and efficacy of ponatinib in children. Two sites are actively recruiting in Belgium and Spain. Further sites will participate in Belgium, Denmark, France, Germany, Italy, Netherlands, Sweden, Spain and the United Kingdom.
  • TIPI = an open trial to assess ponatinib followed by imatinib in patients with CML in chronic phase in France. There are plans to expand the inclusion criteria and open further sites in France and Switzerland if no safety warnings are detected in a preliminary assessment.
  • PONAZA = an open trial to assess the efficacy and tolerance of ponatinib plus azacytidine in patients with CML in accelerated phase or in myeloid blast crisis in France. Recruitment is currently on hold for administrative reasons.
  • RT51KRI03 = a trial to evaluate the efficacy and safety of radotinib as second-line treatment in patients with CML in chronic phase in South Korea. This study will also be conducted in Turkey and the Ukraine.
  • RERISE China = a trial to evaluate the efficacy of radotinib as first-line treatment in patients with CML in chronic phase in China.
  • ENDURE = a discontinuation trial to assess the efficacy and safety of ropeginterferon in CML patients in remission in France and Germany.

For a number of trials (KISS, PONS, ASCEMBL, ASC4MORE, CALLS, CLR_15_03), new sites were opened in the following countries:

list 1

 

Check here CML Trials Registry 

We encourage patients as well as patient organisations to consult doctors for personal advice and further information about these studies and/or their scientific contact and study staff for the most up-to-date study information.

If you are aware of any study that is not yet listed in our Clinical Trials Register, please let us know by filling out this form. Thanks for your support!

The latest news from the network

CML Life is joining the network!

CML Life is joining the network!

At the CML Advocates Network, we strive to bring the best resources to CML patient advocates and caregivers around the world. It is with this in mind, we agreed with Incyte to take ownership of CML...

read more
Free CML Education Webcast

Free CML Education Webcast

Our friends from The Leukemia & Lymphoma Society are organising free CML Education Webcast that will be on September 28th, 2022! REGISTER...

read more
CML Horizons 2022 – Registration is now open

CML Horizons 2022 – Registration is now open

Registration info – Preliminary Program – Conference fee – Scholarship Application – Call for Poster – Call for Nominations – Travel – Visas – Venue & Accommodation – Acknowledgements DATE: 28th...

read more